Applications of immunohistochemistry


Introduction

The histological diagnosis is often clear from light microscopic examination of tinctorial-stained slides. However, in cases with varying differential diagnoses, or where molecular subtleties will add to case interpretation, immunohistochemistry may be employed to reach a conclusion. In certain circumstances, immunohistology also has a role in predicting prognosis and potential response to therapy.

It is beyond the scope of this text to provide a comprehensive list of all possible applications and the hundreds of antibodies currently available. Other excellent texts devoted entirely to that task are available (Further reading: ; ) and there are several internet-based resources (e.g. Immunohistochemistry vade mecum, Paul Bishop, see below). This appendix attempts to provide an overview of the ways in which immunohistochemistry is commonly employed in the diagnostic pathology laboratory, alongside the basic immunohistochemical panels in common usage.

The most frequent application of immunohistology is to consider the nature of neoplasms whose morphology overlaps a range of diagnostic categories. However, other applications include identification of infective agents e.g. CMV, HSV, Helicobacter. pylori , deposition of immune complexes in renal and skin disease, and typing of active cell populations, e.g. Bcl-2, Ki67.

Classification of neoplasia

A common application of immunohistochemical staining is the classification of neoplasms according to the type of cellular differentiation. Previously, histochemistry and electron microscopy were used to identify cytoplasmic features which may indicate differentiation toward a particular cell type. However, immunohistochemistry has largely superseded electron microscopy.

Anaplastic tumors

These are typically composed of relatively large, pleomorphic cells with highly atypical nuclei which do not resemble any particular normal tissue type, i.e. they lack differentiation. The list of differential diagnoses is therefore wide and may include neoplasms of epithelial, hematopoietic, melanocytic, mesenchymal, and in the central nervous system, glial origin. Expense and tissue may be spared by performing stains in a tiered fashion, where the first wave of tests is designed to place a neoplasm into one of the major diagnostic categories, and the second and subsequent tiers are used for subclassification. Using this approach, the following table shows a typical panel of stains which would be used in the first tier of assessment.

Anaplastic tumors
Broad spectrum cytokeratins (AE1/3, MNF116, Cam 5.2) Lymphoid marker (CD45) Melanocytic markers (Melan A, S100, HMB45) Mesenchymal marker (Vimentin) CNS 1 marker (GFAP) 2
Epithelial origin/carcinoma + Some are positive
Hematopoietic/lymphoid +
Melanocytic +
Mesenchymal/sarcoma +/− +/− +
Central nervous system/glial +/− +

1 Central nervous system.

2 Glial fibrillary acid protein.

Small round cell tumors

This group of poorly differentiated neoplasms consists of small, immature/somewhat fetal-type cells with relatively round densely stained nuclei and scant cytoplasm. A panel of antibodies which would be useful in distinguishing among these differential diagnostic possibilities is shown in the following table.

Small round cell tumors
CD99 CD45 Cytokeratin Desmin Neural markers (e.g. CD56) Muscle markers (e.g. MyoD1) WT1
Differential diagnosis in children and adults
Ewing’s sarcoma/PNET 1 + −/+ +
Neuroblastoma +
Desmoplastic small round cell tumor + + + + +
Wilms’ tumor −/+ (focal) −/+ (blastema) −/+ (blastema) −/+ (blastema) +
Rhabdomyosarcoma + −/+ + +
Lymphoma + +
Differential diagnosis predominantly in adults
Synovial sarcoma + + +
Small cell carcinomas + +

1 Primitive neuroectodermal tumor.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here